π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This single arm pilot phase I study with safety run-in is designed to estim...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2022-11-03
Trial ID
NCT05011422
Treatments Being Tested
The purpose of the study is to determine the best treatment approach based ...
Status
Not Yet Recruiting
Location
Beth Israel Deaconess Medical Center (BIDMC)
Start Date
2026-06-08
Trial ID
NCT07624513
The purpose of this study is to evaluate the effectiveness of Bortezomib wh...
Status
Completed
Location
H. Lee Moffitt Cancer Center
Start Date
2009-06-18
Trial ID
NCT00948922
Treatments Being Tested
This phase II trial studies how well giving cyclophosphamide and anti-thymo...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2011-09-15
Trial ID
NCT01413100
Background: X-linked severe combined immunodeficiency (XSCID) is a rare in...
Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Start Date
2025-05-09
Trial ID
NCT06851767
Treatments Being Tested
Severe aplastic anemia is a life-threatening bone marrow failure disorder. ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-15
Trial ID
NCT07629947
Liver transplantation (LT) is a current life-saving procedure performed as ...
Status
Completed
Location
Memorial Hospital Groups
Start Date
2018-09-19
Trial ID
NCT04546048
Treatments Being Tested
The purpose of this research study is:(1) to determine if high doses of che...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-05
Trial ID
NCT00582933
This study will gather information about the combination the drugs plerixaf...
Status
Completed
Location
Washington University School of Medicine
Start Date
2011-04-01
Trial ID
NCT01158118
Treatments Being Tested
This is a non-randomized, open label, multi-site, single dose, Phase 1/2 st...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-02
Trial ID
NCT02140554
Treatments Being Tested